In Silico and Ex Vivo Analyses of the Inhibitory Action of the Alzheimer Drug Posiphen and Primary Metabolites with Human Acetyl- and Butyrylcholinesterase Enzymes

[Image: see text] Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide. Ongoing research to develop AD treatments has characterized multiple drug targets including the cholinergic system, amyloid-β peptide, phosphorylated tau, and neuroinflammation. These systems have the...

Descripción completa

Detalles Bibliográficos
Autores principales: Batool, Sidra, Furqan, Tiyyaba, Hasan Mahmood, Muhammad Sibte, Tweedie, David, Kamal, Mohammad A., Greig, Nigel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845043/
https://www.ncbi.nlm.nih.gov/pubmed/35178511
http://dx.doi.org/10.1021/acsptsci.1c00200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845043/
https://www.ncbi.nlm.nih.gov/pubmed/35178511
http://dx.doi.org/10.1021/acsptsci.1c00200

Ejemplares similares